GE HealthCare is trading approximately 6% higher at $67.94 in pre-market trading after reaffirming its positive second-quarter outlook and preliminary financial results.
- The company's previously reported 5.7% revenue increase and better-than-expected EPS continue to attract buyers amid an upbeat industry backdrop.
- The move comes as healthcare stocks broadly rally following strong Q2 earnings reports across the sector.